Synlogic announces reverse stock split

Cambridge, mass., sept. 27, 2023 (globe newswire) -- synlogic, inc. (nasdaq: sybx), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today announced that it will implement a 1-for-15 reverse stock split of its common stock (reverse stock split), effective at 5:00 p.m. eastern time on wednesday, september 27, 2023. the reverse stock split, which was approved by shareholders at the company's annual meeting of stockholders on september 21, 2023, is primarily intended to bring the company into compliance with the minimum bid price requirement for maintaining its listing on the nasdaq capital market. beginning with the opening of trading tomorrow, thursday, september 28, 2023, the company's common stock will trade on the nasdaq capital market on a split-adjusted basis under the existing symbol “sybx” and a new cusip number 87166l 209.
SYBX Ratings Summary
SYBX Quant Ranking